$XLO stock is up 102% today. Here's what we see in our data.

$XLO stock has now risen 102% today, according to our price data from Polygon. There has been approximately $121,311,348 of trading volume.

$XLO Insider Trading Activity

$XLO insiders have traded $XLO stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $XLO stock by insiders over the last 6 months:

• SCIENCES, INC. GILEAD purchased 1,759,978 shares for an estimated $1,830,377

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$XLO Hedge Fund Activity

We have seen 11 institutional investors add shares of $XLO stock to their portfolio, and 9 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC added 781,367 shares (+20.6%) to their portfolio in Q3 2024, for an estimated $615,482
• MORGAN STANLEY added 409,362 shares (+36.8%) to their portfolio in Q3 2024, for an estimated $322,454
• GEODE CAPITAL MANAGEMENT, LLC added 155,337 shares (+85.0%) to their portfolio in Q3 2024, for an estimated $122,358
• ENGINEERS GATE MANAGER LP added 32,752 shares (+inf%) to their portfolio in Q3 2024, for an estimated $25,798
• TWO SIGMA SECURITIES, LLC added 31,174 shares (+234.9%) to their portfolio in Q3 2024, for an estimated $24,555
• RENAISSANCE TECHNOLOGIES LLC removed 28,700 shares (-9.7%) from their portfolio in Q3 2024, for an estimated $22,606
• MARINER, LLC added 25,317 shares (+inf%) to their portfolio in Q3 2024, for an estimated $19,942

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

You can track data on $XLO on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.